Differentiation in T.cruzi:an emerging AIDS pathogen

克氏锥虫的分化:一种新出现的艾滋病病原体

基本信息

  • 批准号:
    7219517
  • 负责人:
  • 金额:
    $ 35.41万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2005
  • 资助国家:
    美国
  • 起止时间:
    2005-04-01 至 2010-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The protozoan parasite Trypanosoma cruzi, the causative agent of Chagas' disease, has emerged as a HIV/AIDS-related opportunistic infection. Current anti-T. cruzi agents are highly toxic, and there is no effective treatment for chronic Chagas' disease. Improvement in our understanding of the molecular signaling responsible for its differentiation may lead to effective inhibitors of these processes providing new and novel therapeutic approaches. Differentiation of T. cruzi involves cAMP, but the pathway in which it is acting remains unknown. It is likely, that as in other eukaryotes, cAMP-dependent protein kinase (PKA) is a major signal transduction pathway controlling cell differentiation. The PKA catalytic subunit (TcPKA-C) gene and the PKA regulatory subunit gene (TcPKA-R) of T. cruzi were cloned by our laboratory and data indicates that the PKA catalytic and regulatory subunits are developmentally regulated. These data support the hypothesis that PKA activity is important in T. cruzi stage differentiation. We now plan to study the functions of TcPKA in differentiation. The effects of both overexpression of TcPKA with a constitutively active TcPKAC and blockade of TcPKA with a PKI clone, a dominant negative inhibitory TcPKA-R as well as conditional knockout of TcPKA-C on differentiation and proliferation will be studied in transfected parasites. Mechanisms of intracellular targeting of TcPKA-R in T. cruzi will be examined by deletion analysis of Nterminus of TcPKA-R and by analyzing the post-translational modifications of TcPKA-R with mass spectrometry. To further delineate the components of this pathway, we will identify the TcPKA downstream interacting molecules, using both yeast two-hybrid assays and proteomic approaches.
描述(由申请人提供):原生动物寄生虫克氏锥虫是南美锥虫病的病原体,已成为一种与艾滋病毒/艾滋病相关的机会性感染。当前抗T。克鲁兹毒剂具有剧毒,慢性恰加斯病尚无有效治疗方法。我们对负责其分化的分子信号传导的理解的提高可能会导致这些过程的有效抑制剂,从而提供新的治疗方法。克氏锥虫的分化涉及 cAMP,但其作用途径仍不清楚。与其他真核生物一样,cAMP 依赖性蛋白激酶 (PKA) 很可能是控制细胞分化的主要信号转导途径。本实验室克隆了克氏锥虫的PKA催化亚基(TcPKA-C)基因和PKA调节亚基基因(TcPKA-R),数据表明PKA催化亚基和调节亚基受到发育调控。这些数据支持这样的假设:PKA 活性在克氏锥虫阶段分化中很重要。 We now plan to study the functions of TcPKA in differentiation.将在转染的寄生虫中研究用组成型活性 TcPKAC 过表达 TcPKA 和用 PKI 克隆、显性失活抑制性 TcPKA-R 阻断 TcPKA 以及条件性敲除 TcPKA-C 对分化和增殖的影响。将通过 TcPKA-R N 末端的缺失分析以及通过质谱分析 TcPKA-R 的翻译后修饰来检查 T. cruzi 中 TcPKA-R 的细胞内靶向机制。为了进一步描述该途径的组成部分,我们将使用酵母双杂交测定和蛋白质组学方法来鉴定 TcPKA 下游相互作用分子。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Huan Huang其他文献

Huan Huang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Huan Huang', 18)}}的其他基金

New molecular techniques for T. cruzi
克氏锥虫的新分子技术
  • 批准号:
    8660617
  • 财政年份:
    2013
  • 资助金额:
    $ 35.41万
  • 项目类别:
New molecular techniques for T. cruzi
克氏锥虫的新分子技术
  • 批准号:
    9132477
  • 财政年份:
    2013
  • 资助金额:
    $ 35.41万
  • 项目类别:
New molecular techniques for T. cruzi
克氏锥虫的新分子技术
  • 批准号:
    8581382
  • 财政年份:
    2013
  • 资助金额:
    $ 35.41万
  • 项目类别:
Differentiation in T.cruzi:an emerging AIDS pathogen
克氏锥虫的分化:一种新出现的艾滋病病原体
  • 批准号:
    6946961
  • 财政年份:
    2005
  • 资助金额:
    $ 35.41万
  • 项目类别:
Differentiation in T.cruzi:an emerging AIDS pathogen
克氏锥虫的分化:一种新出现的艾滋病病原体
  • 批准号:
    7596947
  • 财政年份:
    2005
  • 资助金额:
    $ 35.41万
  • 项目类别:
Differentiation in T.cruzi:an emerging AIDS pathogen
克氏锥虫的分化:一种新出现的艾滋病病原体
  • 批准号:
    7013619
  • 财政年份:
    2005
  • 资助金额:
    $ 35.41万
  • 项目类别:
Differentiation in T.cruzi:an emerging AIDS pathogen
克氏锥虫的分化:一种新出现的艾滋病病原体
  • 批准号:
    7385888
  • 财政年份:
    2005
  • 资助金额:
    $ 35.41万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 35.41万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 35.41万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 35.41万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 35.41万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 35.41万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 35.41万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 35.41万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 35.41万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 35.41万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 35.41万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了